Practice management in the era of anti-VEGF therapy (Part I)

Article

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Recent Videos
EURETINA 2024: Andrea Govetto, MD, PhD, speaks about macular oedema and the Ramin Tadayoni Award
Ricardo Letião Guerra, MD, MSc, FICO, speaks with Hattie Hayes of Ophthalmology Times Europe
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
Related Content
A flag for the European Union outside a government building. Image credit: ©ArtJazz – stock.adobe.com

EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)

Hattie Hayes
September 20th 2024
Article

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A person with glasses and a hearing aid looks at her phone. Image credit: ©Oleksandr – stock.adobe.com

EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment

Lynda Charters
September 20th 2024
Article

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A clinician administers a COVID-19 vaccine to a patient. Both wear masks. Image credit: ©Jacob Lund – stock.adobe.com

EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination

Lynda Charters
September 19th 2024
Article

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

A human heart paired with a digital display of an echocardiogram. Image credit: ©Sergey Nivens – stock.adobe.com

EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure

Lynda Charters
September 19th 2024
Article

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

© 2024 MJH Life Sciences

All rights reserved.